The German pharmaceutical market is the largest in Europe and is predicted to grow to $65 billion by 2020. But where exactly is it headed in the future?
This topic is explored in an article published in PharmaVOICE, where Dr Detlev Haack (Director of Research & Development at HERMES PHARMA), and other industry professionals, discuss:
- The German pharmaceutical industry, highlighting the country’s strong focus on R&D, the large generics market, and the need for quality to be incorporated into drug development
- The German healthcare system, including the value-based system for medicine pricing
- General market trends, such as the increasingly important roles of digital healthcare and big data, and the need for partnerships to drive innovation